-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Initiates Coverage On Seaport Therapeutics with Buy Rating, Announces Price Target of $35

Benzinga·05/26/2026 20:01:12
Listen to the news
Citigroup analyst Yigal Nochomovitz initiates coverage on Seaport Therapeutics (NASDAQ:SPTX) with a Buy rating and announces Price Target of $35.